The Journal of Immunological Sciences is pleased to announce a special issue dedicated to Clade 1b Mpox, focusing on the unique challenges and insights associated with this specific strain of the virus. As Clade 1b continues to pose significant public health concerns, it is crucial to understand its genetic makeup, transmission dynamics, and the effectiveness of current prevention and treatment strategies.

This special issue seeks contributions from a wide range of disciplines, including virology, epidemiology, public health, and clinical medicine. We aim to provide a comprehensive platform for cutting-edge research and discussions that will advance our collective knowledge and inform global health policies.

Topics of Interest Include:

• Genetic Variations and Evolution: Studies exploring the molecular and genetic characteristics of Clade 1b, its evolution, and implications for vaccine development.
• Epidemiological Studies and Outbreak Analysis: Research focusing on the spread, transmission patterns, and risk factors associated with Clade 1b outbreaks.
• Innovations in Diagnostics and Treatment: New diagnostic tools, therapeutic approaches, and clinical management strategies specific to Clade 1b Mpox.
• Vaccine Development and Efficacy: Evaluation of existing vaccines, novel vaccine candidates, and their effectiveness against Clade 1b.
• Public Health Responses and Policy Recommendations: Analyses of public health interventions, policy frameworks, and their effectiveness in controlling Clade 1b outbreaks.

Submission Guidelines: Authors are encouraged to submit original research articles, reviews, case studies, and commentary pieces that contribute to a deeper understanding of Clade 1b Mpox. Submissions should adhere to the journal’s standard manuscript guidelines.

Why Contribute? Publishing in this special issue offers the opportunity to share your research with an international audience of experts in immunology and public health. Your contributions will help shape future research directions and inform global strategies for managing and preventing Clade 1b Mpox outbreaks.

For inquiries or further information, please contact at editor@immunologyresearchjournal.com.

We look forward to receiving your valuable submissions and contributing to the global effort to combat Clade 1b Mpox.